Obesity As a Risk Factor for Severe COVID-19 in Hospitalized Patients: Epidemiology and Potential Mechanisms

Overview

Journal Healthcare (Basel)

Specialty Health Services

Date 2022 Oct 27

PMID 36292285

Authors

Scarleth Aburto

Mischka Cisterna

Javiera Acuna

Camila Ruiz

Sharon Viscardi

Jose Luis Marquez

Ines Villano

Pablo Letelier

Neftali Guzman

Affiliations

Soon will be listed here.

Abstract

SARS-CoV-2 infection is a global public health problem, causing significant morbidity and mortality. Evidence shows that obesity is a recognized risk factor for hospitalization, admission to critical care units, and the development of serious complications from COVID-19. This review analyzes the available epidemiological evidence that relates obesity to a higher risk of severity and mortality from COVID-19, examining the possible pathophysiological mechanisms that explain this phenomenon on a cellular and molecular level.

Citing Articles

Impact of Obesity-Associated SARS-CoV-2 Mutations on COVID-19 Severity and Clinical Outcomes.

Martinez-Martinez A, Tristancho-Baro A, Garcia-Rodriguez B, Clavel-Millan M, Palacian M, Milagro A Viruses. 2025; 17(1).

PMID: 39861827 PMC: 11769164. DOI: 10.3390/v17010038.

Serological survey in a university community after the fourth wave of COVID-19 in Senegal.

Thiam F, Diouara A, Ndiaye C, Diouf I, Kebe K, Senghor A PLoS One. 2024; 19(11):e0298509.

PMID: 39570844 PMC: 11581233. DOI: 10.1371/journal.pone.0298509.

Identifying Mortality Predictors in Hospitalized COVID-19 Patients: Insights from a Single-Center Retrospective Study at a University Hospital.

Zahornacky O, Rovnakova A, Surimova M, Porubcin S, Jarcuska P Microorganisms. 2024; 12(5).

PMID: 38792861 PMC: 11124314. DOI: 10.3390/microorganisms12051032.

Exploring the intersection of obesity and gender in COVID-19 outcomes in hospitalized Mexican patients: a comparative analysis of risk profiles using unsupervised machine learning.

Nezhadmoghadam F, Tamez-Pena J, Martinez-Ledesma E Front Public Health. 2024; 12:1337432.

PMID: 38699419 PMC: 11063238. DOI: 10.3389/fpubh.2024.1337432.

NASAFYTOL supplementation in adults hospitalized with COVID-19 infection: results from an exploratory open-label randomized controlled trial.

Gerain J, Uebelhoer M, Costes B, Herman J, Pietri S, Donneau A Front Nutr. 2023; 10:1137407.

PMID: 37426178 PMC: 10324407. DOI: 10.3389/fnut.2023.1137407.

References

E Silva J, Pereira Vasconcelos A, Noma I, Noronha N, Aquino R, Giddaluru J . Gene signatures of autopsy lungs from obese patients with COVID-19. Clin Nutr ESPEN. 2021; 44:475-478. PMC: 8149170. DOI: 10.1016/j.clnesp.2021.05.004. View

Pettit N, MacKenzie E, Ridgway J, Pursell K, Ash D, Patel B . Obesity is Associated with Increased Risk for Mortality Among Hospitalized Patients with COVID-19. Obesity (Silver Spring). 2020; 28(10):1806-1810. PMC: 7362135. DOI: 10.1002/oby.22941. View

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

Chu Y, Yang J, Shi J, Zhang P, Wang X . Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis. Eur J Med Res. 2020; 25(1):64. PMC: 7708895. DOI: 10.1186/s40001-020-00464-9. View

Stefan N, Birkenfeld A, Schulze M . Global pandemics interconnected - obesity, impaired metabolic health and COVID-19. Nat Rev Endocrinol. 2021; 17(3):135-149. DOI: 10.1038/s41574-020-00462-1. View

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

Alegre-Diaz J, Friedrichs L, Ramirez-Reyes R, Wade R, Bragg F, Herrington W . Body mass index and COVID-19 mortality: prospective study of 120 000 Mexican adults. Int J Epidemiol. 2022; 51(5):1698-1700. PMC: 9214141. DOI: 10.1093/ije/dyac134. View

Han H, Yang L, Liu R, Liu F, Wu K, Li J . Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020; 58(7):1116-1120. DOI: 10.1515/cclm-2020-0188. View

Rottoli M, Bernante P, Belvedere A, Balsamo F, Garelli S, Giannella M . How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre. Eur J Endocrinol. 2020; 183(4):389-397. PMC: 9494325. DOI: 10.1530/EJE-20-0541. View

10.

Wolff D, Nee S, Hickey N, Marschollek M . Risk factors for Covid-19 severity and fatality: a structured literature review. Infection. 2020; 49(1):15-28. PMC: 7453858. DOI: 10.1007/s15010-020-01509-1. View

11.

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

12.

Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H . Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020; 130(5):2620-2629. PMC: 7190990. DOI: 10.1172/JCI137244. View

13.

Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F . Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission. Clin Infect Dis. 2020; 71(15):896-897. PMC: 7184372. DOI: 10.1093/cid/ciaa415. View

14.

de Leeuw A, Oude Luttikhuis M, Wellen A, Muller C, Calkhoven C . Obesity and its impact on COVID-19. J Mol Med (Berl). 2021; 99(7):899-915. PMC: 8023779. DOI: 10.1007/s00109-021-02072-4. View

15.

Lasbleiz A, Gaborit B, Soghomonian A, Bartoli A, Ancel P, Jacquier A . COVID-19 and Obesity: Role of Ectopic Visceral and Epicardial Adipose Tissues in Myocardial Injury. Front Endocrinol (Lausanne). 2021; 12:726967. PMC: 8415546. DOI: 10.3389/fendo.2021.726967. View

16.

Varga Z, Flammer A, Steiger P, Haberecker M, Andermatt R, Zinkernagel A . Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395(10234):1417-1418. PMC: 7172722. DOI: 10.1016/S0140-6736(20)30937-5. View

17.

Palma G, Sorice G, Genchi V, Giordano F, Caccioppoli C, DOria R . Adipose Tissue Inflammation and Pulmonary Dysfunction in Obesity. Int J Mol Sci. 2022; 23(13). PMC: 9267094. DOI: 10.3390/ijms23137349. View

18.

Fruhbeck G, Catalan V, Valenti V, Moncada R, Gomez-Ambrosi J, Becerril S . FNDC4 and FNDC5 reduce SARS-CoV-2 entry points and spike glycoprotein S1-induced pyroptosis, apoptosis, and necroptosis in human adipocytes. Cell Mol Immunol. 2021; 18(10):2457-2459. PMC: 8405856. DOI: 10.1038/s41423-021-00762-0. View

19.

Adnan Mezher M, Bahjat Alrifai S, Mahmood Raoof W . Analysis of Proinflammatory Cytokines in COVID-19 Patients in Baghdad, Iraq. Arch Razi Inst. 2023; 78(1):305-313. PMC: 10258264. DOI: 10.22092/ARI.2022.359356.2411. View

20.

Wu X, Li C, Chen S, Zhang X, Wang F, Shi T . Association of body mass index with severity and mortality of COVID-19 pneumonia: a two-center, retrospective cohort study from Wuhan, China. Aging (Albany NY). 2021; 13(6):7767-7780. PMC: 8034951. DOI: 10.18632/aging.202813. View